Trial intelligence / Profile preview

Phase IIa randomized double-blind placebo-controlled study of oral SSS17 (HIF-117) capsules for postoperative anemia after hip or knee arthroplasty

CTR20252348Phase 2Active

Sponsor
3SBio
Start
Jun 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of SSS-17 in postoperative anemia, sponsored by 3SBio. Started Jun 2025; status: active.

02

Drugs

SSS-17
03

Conditions

postoperative anemia

Beyond the preview

Go deeper on CTR20252348.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20252348.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call